These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15725110)

  • 1. Risk assessment: controversies and management of moderate- to high-risk individuals.
    Brown P
    Breast J; 2005; 11 Suppl 1():S11-9. PubMed ID: 15725110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and follow-up of the patient at high risk for breast cancer.
    Willey SC; Cocilovo C
    Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.
    Warner E; Heisey RE; Goel V; Carroll JC; McCready DR
    Can Fam Physician; 1999 Jan; 45():104-12. PubMed ID: 10889863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the BRCA mutation carrier or high-risk patient.
    Bordeleau LJ; Lipa JE; Neligan PC
    Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and risk assessment for breast cancer: molecular and clinical aspects.
    Beckmann MW; Bani MR; Fasching PA; Strick R; Lux MP
    Maturitas; 2007 May; 57(1):56-60. PubMed ID: 17386982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer prevention: from chemoprevention to prophylactic surgery].
    Morcel K; Rouquette S; Dugast C; Bendavid C; Audrain O; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2008 Nov; 37(7):661-71. PubMed ID: 18653291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Models for risk assessment and prediction in breast cancer].
    Hu Z; Li X; Feng MH; Chu JJ; Xie W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1073-7. PubMed ID: 20193393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
    Schwartz GF; Hughes KS; Lynch HT; Fabian CJ; Fentiman IS; Robson ME; Domchek SM; Hartmann LC; Holland R; Winchester DJ;
    Cancer; 2008 Nov; 113(10):2627-37. PubMed ID: 18853415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
    Chappuis PO
    Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
    Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a family risk assessment clinic for breast cancer.
    Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
    Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.